Loading stock data…
$0.86+0.01 (+0.62%)
Lucyd, Inc develops and sells smart eyewear in North America.
Lucyd, Inc in the Healthcare sector is trading at $0.86 with a market capitalization of $7M. The stock is currently near its 52-week low of $0.65, remaining 14.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.01M↑ | $773,561↓ | $959,810↑ | $668,128↑ | $579,230 |
| Gross Profit | $242,515↑ | $175,445↑ | $114,746↓ | $244,837↑ | -$12,665 |
| Operating Income | -$1.70M↑ | -$2.37M↑ | -$2.50M↓ | -$1.92M↑ | -$2.17M |
| Net Income | -$1.67M↑ | -$2.31M↓ | -$1.87M↓ | -$1.84M↑ | -$2.11M |
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescript...